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Precursor  and  mature  NGF  live  
tracking:  one  versus  many  at  a  time  
in  the  axons
Teresa  De  Nadai?,  Laura  Marchetti?,?,  Carmine  Di  Rienzo?,?,  Mariantonietta  Calvello?,  
Giovanni  Signore?,  Pierluigi  Di  Matteo?,  Francesco  Gobbo?,  Sabrina  Turturro?,  
Sandro  Meucci?,?,  Alessandro  Viegi?,  Fabio  Beltram?,?,  Stefano  Luin?  &  Antonino  Cattaneo?
The  classical  view  of  nerve  growth  factor  (NGF)  action  in  the  nervous  system  is  linked  to  its  retrograde  
?????????????????? ?????????? ????????????????????????????????????????????????? ??????????????????
?????????? ????????????????????? ?? ?????????????????????? ???????? ???????????????????? ????????????
??????? ??????????????????? ???? ?? ??????????????????????? ?????????? ??????????????????????????
mature  neurotrophins  (NTs)  with  a  controlled  stoichiometry  and  insertion  site.  Using  a  single  particle  
tracking  approach,  we  characterized  the  axonal  transport  of  proNGF  versus  mature  NGF  in  living  
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of  neurotrophins  per  vesicle.  Moreover,  exploiting  a  dual-­‐color  labelling  technique,  we  analysed  the  
transport  of  both  NT  forms  when  simultaneously  administered  to  the  axon  tips.
!e reciprocal levels of Nerve Growth Factor (NGF) and of its unprocessed precursor (proNGF) play a crucial 
role in regulating the survival/death balance of several neuronal populations in physiopathological conditions1–4. 
proNGF, which is the most abundant form of NGF in the brain5, can either act as an intracellular or secreted 
precursor for mature NGF or remain unprocessed, activating survival/di"erentiation or apoptosis pathways, 
respectively. !is molecular switch relies on the di"erent receptor binding pro#les, determining di"erent biolog-
ical outcomes. When administered separately or together, NGF and proNGF activate distinct and peculiar gene 
expression patterns in target cells6,7. Disruption of the NGF to proNGF balance has been causally linked to neu-
rodegeneration8,9, and the proNGF versus NGF ratio is increased in the cortex of Alzheimer’s disease patients5. 
!us, describing the signaling mechanisms that link NGF and proNGF cellular tra$cking to their speci#c biolog-
ical function is of crucial importance.
Axonal transport of neurotrophins (NTs) represents a crucial link between receptor mediated signaling and 
their biological outcome10. Despite its importance, we currently lack the molecular de#nition and characteriza-
tion of NTs axonal signalling endosomes11. Furthermore, the question of whether and how pro-NTs move ret-
rogradely or anterogradely along axons, in comparison to their mature counterparts, has remained so far largely 
unexplored. We have addressed these issues by using a biophysical approach of NT labeling and tracking in living 
neurons. Ideally, a quantitative comparison between the axonal transport of NGF and proNGF requires the two 
molecules to be %uoro-labeled at the same molecular site and with the same stoichiometry. So far, the mature 
forms of NTs have been chemically coupled to organic %uorophores12–16 or to biotin17–21. While this has allowed 
obtaining valuable information about NGF tra$cking, it has not been possible to control the exact number and 
site of conjugated probes, so that mixed and not fully reproducible labeled protein populations are obtained. 
Similar approaches are not recommended for the purpose of labeling proNGF, whose pro-domain has features 
of an intrinsically unfolded protein22,23, nor for a detailed side-by-side comparison of the mature and precursor 
forms.
Here a novel %uorolabeling strategy is described, allowing for the production of “homologous” %uorescent 
human NGF and proNGF, based on the insertion of an 11 amino acid tag at the at the C- terminus of the pro-
tomer sequence. !e inserted tag is a target for a site-speci#c enzymatic covalent binding and it is used here to 
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bind a small organic dye, so that a site-speci#c %uorophore conjugation with 1:1 (label:NT-monomer) stoichi-
ometry is obtained for both the unprocessed and mature forms of NGF. !e technique allows for a high (≈ 80%) 
%uorescent NT production yield and for an optimal puri#cation from the unlabeled counterparts. !e obtained 
labelled species retain the same functional features of the native proteins. Fluorescence microscopy experiments 
were performed on compartmentalized living cultures of rat dorsal root ganglion (DRG) neurons, in which %uo-
rescent proNGF and NGF were administered either separately or together. !e #rst direct evidence that proNGF 
is retrogradely transported like mature NGF is provided here, although important di"erences of the axonal trans-
port of the two molecules have been uncovered. Crucially, the controlled stoichiometry of the labelling reaction 
allowed quantifying the number of NTs in each vesicle, showing a signi#cant di"erence between their distribu-
tions in the two cases. Moreover, by coadministering both neurotrophins labelled with di"erent %uorophores, we 
were able to analyse the cotransport of precursor and mature neurotrophins in neurons.
Results
Fluo-­‐proNGF  and  Fluo-­‐NGF  synthesis  and  functional  validation.   We recently explored the pos-
sibility of chemically modifying NTs by the insertion of short tags derived from the acyl and peptidyl carrier 
proteins24. Following this approach, a single %uorophore per monomer of proNGF or NGF was conjugated by 
introducing a short amino acidic tag at the C-terminus of the proNGF sequence (Fig. 1A,B), by exploiting a 
site-speci#c enzymatic reaction to covalently link the small organic dye to a serine residue of the tag (Fig. 1C). 
!e C-terminal portion of NTs was chosen as a permissive site to insert the tag with minimal interference with 
NGF structure and receptor binding24.
In order to optimize both expression and labelling yields, as well as to assure the maintenance of NT physio-
logical activity, four di"erent tag sequences were compared (spanning from 8 to 12 amino acids): YBBR, A4, A1, 
and S6 (Fig. 1C)25–27. !e production yields obtained for all the tagged NTs a'er their expression, refolding and 
puri#cation from E.Coli inclusion bodies22,28 (Supplementary Figure 1A) were compared to those obtained for the 
untagged counterparts (Fig. 1D): while for all tagged constructs the precursor NT could be successfully puri#ed 
(although with di"erent yields: YBBR > A4 > A1 > S6), only two of the tags (YBBR > A4) consistently yielded 
measurable amounts of puri#ed mature protein. Accordingly, NGF-YBBR and NGF-A4 were further charac-
terized. Tag insertion does not interfere with NGF functionality, according to a number of signaling, cell di"er-
entiation and proliferation assays (Supplementary Figs 1B–D). For labelling purposes, YBBR- and A4- tagged 
precursor or mature NGF proteins were incubated with Coenzyme A (CoA) labelled biotin substrate and Acp- or 
Sfp-synthase PPTases (or no enzyme as control) (Fig. 1E). Data demonstrate that a speci#c biotin labelling is 
achieved for NGF-YBBR in the presence of both enzymes, with a higher labelling yield provided by the reaction 
with Sfp-synthase, while NGF-A4 displays signi#cant labelling only in presence of Acp-synthase but with a lower 
yield compared to the NGF-YBBR/Sfp-synthase reaction. Based on these data, YBBR sequence was identi#ed to 
be the best tag for NGF and proNGF labelling.
Next, YBBR tag was exploited to produce %uorescent proNGF and NGF, herea'er referred as %uo-proNGF and 
%uo-NGF. To this purpose, puri#ed proNGF-YBBR or NGF-YBBR were incubated with CoA-Alexa488 substrate 
in the presence of Sfp-synthase (see Materials and Methods). Upon labelling, %uo-proNGF and %uo-NGF were 
puri#ed by ion exchange chromatography to remove both the free %uorophore and the non-reacted NT, so as to 
recover exclusively %uorescent NTs (Fig. 1F). !e comparison of the various peaks integrals in the chromatogram 
allowed us to estimate a labelling yield of about 80% (see Materials and Methods). In order to validate whether the 
%uorescent NTs retain functional activity, we performed a DNA microarray analysis of gene expression activated 
by 1 hour treatment of PC12 cells with %uo-proNGF or %uo-NGF respectively, and compared the expression 
pro#le with those obtained a'er incubation of equal amounts of the corresponding wt, untagged counterparts. 
Indeed, we have previously demonstrated that this assay is able to #nely discriminate proNGF from NGF func-
tional activity in relatively short timescales, so as to minimize the impact of proNGF cleavage to NGF6. Clustering 
analysis of gene expression pro#les showed that treatments with wt and %uorescent proNGF cluster together, 
while the gene expression pro#le obtained with wt NGF is farther away in the tree and is clustered together with 
%uo-NGF (Fig. 1I). !us, each %uo-NGF and %uo-proNGF neurotrophin induces a global signaling very similar 
to that of the corresponding unmodi#ed neurotrophin. Furthermore, %uo-NGF is able to promote PC12 cells dif-
ferentiation, inducing neurite outgrowth to the same extent as wt NGF (Fig. 1G). Moreover, %uo-NGF induces a 
robust activation of the downstream signaling e"ectors involved in NGF-signaling pathways, like phosphorylated 
Erk1/2, PLC-γ and AKT proteins (Fig. 1H). !ese data indicate that %uorescent NTs are biologically active and 
induce physiological responses comparable to those of the respective native proteins.
fluo-­‐NGF  versus  fluo-­‐proNGF  Axonal  Transport.   Purified fluorolabeled proNGF and NGF were 
employed for axonal transport studies in living DRG neurons, cultured in a micro%uidic chamber divided in 
three compartments29: a soma compartment (SC), where neurons are plated, a channel compartment (CC), where 
neurons extend their axons through micrometer channels, and an axon compartment (AC) where neurons spread 
their axonal tips (Fig. 2A,E,I,M). Each experiment was performed by administering the NT at 2 nM concentration 
in the AC or in the SC and measuring the axonal transport of the protein by epi-%uorescence microscopy and 
single particle tracking of %uorescent vesicles.
First, %uo-NGF was administered to the AC or to the SC and the vesicles tra$cking was measured in the CC 
(Fig. 2A,E). In both cases, %uo-NGF #lled vesicles started to move about 20 minutes a'er NT administration. 
Fluo-NGF vesicles were found to move not only when NGF was delivered to the AC, from the axon tip to the cell 
soma (retrograde movement), but also when delivered to SC, in the opposite direction (anterograde movement). 
Typical recorded trajectories are represented in Fig. 2B, F. Most of the %uo-NGF vesicles move with a stop-and-go 
dynamics, as previously reported17, characterized by variable pausing times (Fig. 2C,G). On the whole, traveling 
vesicles spend about 55% of their time moving (see also Supplementary Fig. 2 and Supplementary Information). 
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Figure 1. Schematic overview of production of !uorescent NTs and characterization of !uo-NGF 
biological activity. (A) Cartoon depicting the two-steps labelling strategy. Structure of human NGF (blue 
ribbon, PDB 1SG1) with overlaid, in grey, the pro-peptide domain22 (Le!); the tag sequence inserted at the 
C-terminal position of proNGF is depicted in red (Middle); the complete structural formula of Alexa488-
maleimide-phosphopantetheinyl is added, highlighted in green (Right). (B) Scheme of proNGF sequence with 
highlighted tag insertion site. (C) Amino acidic sequence of the four screened tags, with the serine residue 
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Labelled vesicles show a wide distribution of average speeds, when %uo-NGF is administered either at the AC or 
at the SC (Fig. 2D,H; positive and negative velocities refer to retrograde and anterograde movements, respectively, 
if not speci#ed otherwise; see also Supplementary Table 1). Notably, in the case of AC-administered %uo-NGF, 
also anterogradely moving vesicles have been observed, about 10 minutes a'er the #rst retrogradely moving 
vesicle was measured. !e speed distribution during the active phase of the overall movement, evaluated by 
separating the “stop” and “go” parts of the trajectories, is shown as solid lines in Fig. 2D,H. !e high number of 
trajectories acquired with SC-applied %uo-NGF allows to conclude that the anterograde transport is slightly, but 
signi#cantly (p < 0.05, Dunns Test), slower than the retrograde transport. On the contrary, the low number of 
anterograde moving vesicles did not allow this comparison in the case of AC-applied %uo-NGF. !e retrograde 
and anterograde average velocities measured by administering %uo-NGF to the AC or the SC are the same within 
uncertainties (see also Supplementary Table 1).
In the case of %uo-NGF applied to the AC, the anterograde population of moving vesicles increases during the 
acquisition, with an average value of 9% (Supplementary Fig. 3A). !is anterograde movement is di"erent from 
the short anterograde displacement seen during vesicle retrograde transport, as frequently observed here and 
previously reported17, and persists for large displacements (up to about 100 µ m, which represents the length of 
the #eld of view) and for long times (more than 60 sec). Furthermore, when %uo-NGF is applied to the SC, about 
20 minutes a'er the appearance of the #rst anterograde-moving vesicles, we observe the appearance of a robust 
transport back to the SC. In this case, the number of vesicles transported back (to the SC), a'er they have had the 
chance of an outward movement, is signi#cantly higher than that (from SC to AC) observed for AC-administered 
NGF (25% of the cases compared to 9%) and, once started, this retrograde %ux to the soma persists quite con-
stantly for hours (Supplementary Fig. 3B).
Next, proNGF vesicular trafficking was examined under the same experimental conditions as above. 
Fluo-proNGF was administered to the AC or to the SC (Fig. 2I,M). We found that a retrograde flux of 
%uo-proNGF vesicles moving from the AC to the SC can be recorded (Fig. 2J), although this is #rst visible a'er a 
longer lag time compared to that of %uo-NGF (starting about 35 minutes a'er NTs administration). Fluo-proNGF 
moving vesicles display the same characteristic stop and go movement seen with %uo-NGF (Fig. 2K,O). Vesicles 
exhibit similar distributions of average speeds and speeds during active movement, compared to the same exper-
iment conducted with mature %uo-NGF. Strikingly, unlike %uo-NGF, when %uo-proNGF was administered to the 
SC we observed no signi#cant anterograde transport through the axons (Fig. 2M); however, as a proof of neuro-
trophin internalization, vesicles tra$cking with directed motion inside axons in the SC was observed (Fig. 2N–P; 
note that in this case a polarity to the movement couldn’t be assigned, hence only positive speed is reported, by 
convention). For comparison, similar measurements for SC applied %uo-NGF are reported in Supplementary 
Fig. 4. Nevertheless, when %uo-proNGF was given to the AC, a small number of anterogradely moving vesicles 
(less than 5%), moving just for short displacements, was observed (the maximum anterograde displacement 
observed is 25 µ m). !ese movements can be con#dently attributed to little steps backwards while the vesicle 
moves retrogradely.
As TrkA and p75 are the main receptors for NGF and proNGF, we investigated by immuno%uorescence which 
of the two receptors mediated the intracellular tra$cking of NGF and proNGF. !e vast majority of %uo-NGF 
particles are associated with TrkA receptors; only a subset of them associates with p75, most prominently at the 
axonal level. Conversely, %uo-proNGF associates with both TrkA and P75 receptors. Notably, we found that when 
%uo-proNGF is present, p75 also colocalizes with TrkA, and that %uo-proNGF particles are associated with p75/
TrkA positive puncta (Supplementary Fig. 5).
???????????????????? ??? ???????????????????????????? ????????? Visual inspection of the experi-
mental acquisitions of %uorescent NGF and proNGF tra$cking (Supplementary Video 1 and 2) suggests that the 
%uorescent intensity of tra$cking vesicles are substantially di"erent in the two cases, despite the identical label-
ling site and stoichiometry for the two proteins. Two representative %uo-NGF and %uo-proNGF labelled vesicles 
are presented in Fig. 3A. We quantitatively analyze the di"erent number of NTs transported by a single vesicle 
in the two cases, thanks to the controlled 1:1 %uorophore:NT-monomer stoichiometry ensured by the labelling 
strategy. To this end, the mean %uorescence intensity from each vesicle was quanti#ed and normalized to the 
covalently conjugated to the %uorophore highlighted in red. (D) Puri#cation yields (mg of product per litre of 
bacterial culture) of tagged proNGF-tag (gray) and NGF-tag (blue), compared to wt (pro)NGF. (E) Western blot 
analysis of the biotinylation reaction of puri#ed NGF-YBBR and NGF-A4 using CoA-biotin substrate and AcpS 
or SfpS PPTases. !e same biotinylation reaction is performed in parallel using untagged wt-NGF as negative 
control. Streptavidin-HRP is used for biotin detection. !e anti-NGF blot (NGF and proNGF lines) is the 
loading control. (F) !e HPLC chromatogram of NGF-YBBR, incubated with CoA-Alexa488 substrate in the 
presence and absence of Sfp-synthase, showing the di"erent retention times of %uorescent and non-%uorescent 
NTs. Absorbance curves at 280 and 490 nm are reported. (G) Typical DIC images of PC12 di"erentiation assay 
using equimolar amounts of wt-NGF and %uo-NGF. Untreated cells are the control. Scale bars represent 20 µ m. 
(H) Western blot analysis of phosphorylated Akt (pAkt), phosphorylated Erk1/2 (pErk1/2) and phosphorylated 
PLCγ (pPLCγ ) protein levels in PC12 cells in response to wt NGF and %uo-NGF, compared to the same 
obtained for untreated cells (No NGF); the signal of the total corresponding signalling e"ectors is the loading 
control. (I) Hierarchical clustering tree of samples, corresponding to the di"erent experimental points (for 
each neurotrophin type four individual PC12 cells administrations were performed). !e trees show the gene 
expression similarity between samples. !e x-axis indicates the distance between samples. Euclidean distance is 
the chosen metric, with average linkage clustering, using all normalized Log2 data.
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reference intensities measured from immobilized single %uorophores (see Fig. 3A and Supplementary Methods 
for details). !e measured number of NT dimers, each carrying two %uorophore molecules, is then used to pro-
duce a 2D histogram in which the number of NTs is presented versus its average speed in Fig. 3B. !e position 
on the Y axis con#rms that the average speed of the NGF and proNGF vesicles is the same. !e X axis shows that 
%uo-NGF vesicles carry a range of NT molecules, spanning from 2 to 8 (full width at half maximum) with a mode 
of 4 dimers per vesicle, while %uo-proNGF vesicles mostly contain a lower number of NTs, from 1 to 4 proNGF 
dimers with a mode value of 1 dimer per vesicle (see also Supplementary Fig. 6).
NGF  competes  with  proNGF  for  axonal  transport.   NGF and proNGF coexist in-vivo, but a direct 
observation of simultaneous axonal transport is still lacking. In order to study the simultaneous axonal transport 
Figure 2. Live axonal transport of !uo-NGF and !uo-proNGF. (A,E,I,M) Schematic picture of the 
micro%uidic device where, in the uppermost panel, the axon compartment (AC), the channel compartment 
(CC), and the soma compartment (SC) are indicated. !e green droplets represent NT administration; a stylized 
microscope indicates the compartment in which %uorescence acquisition is performed; arrows of di"erent 
dimensions schematize the direction and amount of detected moving vesicles. (B,F,J,N) Representative images 
of the time lapse videos of moving vesicles travelling through the axon. Each coloured line represents a single 
vesicle trajectory. (C,G,K,O) Displacement vs time plot of 200 representative vesicles. (D,H,L,P) Bars: average 
speed distribution of moving vesicles. Lines: distribution of speed during active movement. Empty triangles 
indicate the mean of vesicles average speed while #lled triangles indicate the average speed during active 
movements; uncertainties are standard deviations. !e number of acquired trajectories is reported in each 
panel. Distributions with areas normalized to 1; in (C,D,G,H,K,L), positive and negative displacements or 
speeds refer to retrograde and anterograde movements respectively, in the con#guration described in M-P only 
the absolute value of displacements and speeds could be determined.
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of proNGF vs NGF, NTs were conjugated to spectrally distinct probes by using two di"erent CoA-%uorophore sub-
strates: CoA-Alexa647 and CoA-Alexa488 respectively (see Materials and Methods). %uo-NGF and %uo-proNGF 
(Fig. 4A Top) were co-administered, at equimolar (2 nM) concentration, to the AC. A typical dual-colour acqui-
sition of the trajectories recorded in the CC is represented in Fig. 4A, with green and red colours representing 
putative NGF and proNGF vesicles, respectively. Notably, a population of vesicles carrying both %uorophores, 
represented in yellow in Fig. 4A,B, was registered.
!e velocity of dual-labelled vesicles is not signi#cantly di"erent from that of vesicles carrying the individ-
ual NTs (Fig. 4B), and from the velocities registered for the individual administrations of proNGF and NGF 
(Supplementary Fig. 7); however, we noticed that the number of anterogradely moving vesicles of NGF is 
decreased to ~3% of the total in this case (Supplementary Fig. 8). !en, the number of neurotrophin molecules 
carried by vesicles was determined (Fig. 4C). !e distributions of %uo-NGF is quite similar to that observed a'er 
a single administration, while, interestingly, the number of proNGF dimers was markedly reduced at 1 in the vast 
majority of cases, demonstrating a great preference of vesicles to transport mature NGF instead of the precursor 
form (Fig. 4C and Supplementary Fig. 6). Similar conclusions can be drawn by measuring the vesicle %uxes with 
%uo-NGF and %uo-proNGF, given separately or simultaneously at the AC (Fig. 4D). In the case of single admin-
istrations, the number of moving vesicles per 1 mm of axon is 110 ± 42 and 72 ± 38 (mean ± SD) for %uo-NGF 
and for %uo-proNGF respectively. !is indicates that, when administered alone and at the same concentration, 
proNGF vesicles %ux is ~65% of the NGF one. !e %uo-proNGF %ux dramatically drops down to 19 ± 14 vesicles 
per 1 mm of axon (i.e. ~18% of NGF %ux) when the two NT forms are given together, while %uo-NGF vesicles 
%ux is similar to that observed a'er the individual NT administration. Actually, the real proNGF %ux could 
be even lower than that observed due to the possibility of a small fraction of %uo-proNGF being cleaved to its 
mature counterpart during the acquisition time window (Supplementary Fig. 9). !us, upon co-administration 
we observed for proNGF a reduction both in the %ux of vesicles and in the number of neurotrophins per vesicle 
that might stem from competition with NGF or from signaling events caused by NGF and proNGF simultaneous 
administration (see Discussion for more details)7.
Figure 3. Quanti"cation of NTs number carried by each vesicle. (A) Schematization of NT number 
analysis for both %uo-NGF and %uo-proNGF. A representative re-centered vesicle intensity pro#le with the 
corresponding Gaussian #t is reported for both NTs. Scale bar 1µ m. (B) 2D histograms of NT number carried 
by vesicles vs average speed. !e number of analyzed vesicles is reported in each panel.
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Discussion
!e axonal transport of NTs is a crucial aspect of their mode of action in the nervous system. In this context, 
despite the fact that proNGF has a receptor binding pro#le distinct from that of NGF30,31, very little is known 
on how this re%ects in the transport properties of proNGF versus those of mature NGF. We address this issue 
through a novel strategy to %uorolabel puri#ed recombinant precursor and mature NTs with small organic 
dyes, exploiting a recently reported chemical-tag based NT labeling24. !e method has several advantages over 
previously used NT labelling procedures: i) the precise control of stoichiometry (1:1 NT-monomer:probe) 
and site (C-terminus) of %uorophore conjugation; ii) the complete puri#cation of the labelled species from 
unlabelled counterparts as well as from free %uorophores (Fig. 1F); iii) the versatility of the used tags, which 
can be functionalized by virtually any kind of probe, e.g. biotin or %uorophores (Fig. 1E,F), that can be carried 
by coA substrates; iv) the possibility to simultaneously study two “homologue” molecules with orthogonal 
%uorolabels (Fig. 4).
!e obtained %uo-NGF and %uo-proNGF probes allowed here the #rst comparative imaging and tracking 
of proNGF and NGF axonal transport in living DRG neurons by single molecule fluorescence microscopy. 
Results unambiguously show that proNGF is retrogradely transported inside vesicles like its mature counterpart 
(Figs 2–4). proNGF displays the same stop-and-go movements previously reported for NGF and an average speed 
distribution similar to that of NGF. !ese data suggest that the endocytic pathway and related engaged molecular 
motors are conserved between proNGF and NGF. Beside these similarities, the axonal transport of these two 
proteins di"ers from each other in several signi#cant aspects.
First, proNGF vesicles move exclusively from the axon tip to the cell soma of neurons, while NGF vesicles 
exhibit movements in both directions (Fig. 2). While a retrograde tra$cking has been paradigmatically described 
Figure 4. Co-administration of !uo-NGF and !uo-proNGF to the axon compartment. (A) Representative 
images of the time lapse videos of moving vesicles travelling through the axon, at time 0s and a'er 25 sec; 
colocalizing (yellow) indicate the vesicles with both NGF and proNGF. (B) Displacement vs time for a 
representative 10% of all observed vesicles. !e colour code is the same as in panel A. (C) Histograms for 
the number of %uo-proNGF and %uo-NGF per vesicle in non-colocalizing (proNGF red and NGF green) 
vesicles. (D) Histogram representing mean ± SD of the number of vesicles observed per 1mm of axons in 
the single administration of %uo-NGF and %uo-proNGF case (light grey and dark grey bars) and in case 
of coadministration (green and red bars). Dunn’s Multiple Comparison Test was performed, ***indicates 
p < 0.001.
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for mature NGF10, a bidirectional NGF transport has been previously described in neurite-like processes of PC12 
cells, either directly using Cy3.5-NGF13 or indirectly by studying TrkA tra$cking32,33. It should be considered, 
however, that neurites in PC12 do not have comparable biochemical and functional features to DRG ones. In our 
experiments, anterograde (centrifugal) movement when NGF is administered at the AC accounts for ~10% of the 
total vesicles analyzed (Fig. 2C), consistently to what reported, for tracked quantum-dot conjugated NGF17, in the 
same neurons. !e latter study, however, did not quantitatively analyze the 10% anterograde trajectories and did 
not study proNGF. Considering NGF axonal transport as purely retrograde was therefore previously suggested17. 
Nevertheless, we believe this smaller population of anterogradely moving vesicles containing NGF should not be 
neglected because: 1) it is increased (up to ~75%) when NGF is administered to the SC; 2) it is not observed with 
%uo-proNGF applied to the AC nor to the SC; 3) it is decreased to ~3% upon the simultaneous administration of 
proNGF (Supplementary Fig. 8). !ese data point to anterograde centrifugal movement as a speci#c feature of 
NGF but not of proNGF, with the latter interfering with the transport of the former. While these considerations 
strengthen the idea that NGF and proNGF are indeed two di"erent signalling molecules, the biological signif-
icance of the observed anterograde movement remains to be established. It could indeed be that this is a key 
feature of survival/di"erentiation responses; however, it could also be that in our experimental conditions NGF 
in the SC passively exploits the well-known Trk anterograde transport34,35 and that p75 does not support proNGF 
anterograde movement in this cellular model. 
Secondly, proNGF and NGF vesicles contain a di"erent number of molecules per vesicle (Fig. 3). Data 
demonstrate that each vesicle mostly hosts 1 or 2 proNGF and between 2 and 8 NGF dimers, when NTs are 
administered separately, while proNGF number is drastically decreased to one, when NTs are co-administered, 
indicating that NGF provides a veto or competing signal for proNGF internalization and transport. !is #nd-
ing does not appear to match with the recently proposed idea that the typical functional signaling endosome 
consists of a single NT dimer bound to a single pair of TrkA receptors17. Rather, it is consistent with a model 
that envisions the existence of a larger ligand-receptor complex per vesicle, in which a higher number of NTs 
are clustered together. !is discrepancy could arise from the largely di"erent steric hindrance of the two 
%uorolabels used in the two studies. In fact, Cui et al. used Quantum Dots (QD)-conjugated NGF (each QD 
putatively coupled to a single NGF dimer)17. As QD volume is up to 70 times that of NGF (Supplementary Fig. 
10), the QD-NGF conjugate might impair NGF clustering14, thus artifactually preventing the simultaneous 
internalization of several NGF molecules. !is would lead to a decrease in the observed number of QD-NGF 
internalized and transported per vesicle. Conversely, using much smaller organic dyes to %uorolabel NGF, as 
done here, might allow accommodating a physiologically higher number of clustered NGF molecules that 
could easily #nd room in the same vesicle. In this context, it is worth mentioning that, using 125I labelled NGF 
(125I -NGF), Campenot and coworkers36 argued that the total amount of 125I -NGF transported to the soma 
would require two orders of magnitude more vesicles with respect to what measured by Cui et al.17, if such 
vesicles contained only one NGF molecule.
Finally, since in physiological contexts NGF and proNGF coexist, the two forms of the NT were 
co-administrated to the AC (Fig. 4), highlighting a competitive mechanism between them (proNGF %ux and 
number of molecules per vesicle was strongly inhibited and reduced by NGF co-administration). Taking these 
data together with immuno%uorescence data (Supplementary Figure 5), we shall propose two possible mecha-
nisms for the observed competition, which are interestingly not mutually exclusive. First, there could be simply 
a competition for the receptors available on the plasma membrane of the axon tip. Immuno%uorescence analy-
sis shows that the vast majority of %uo-NGF particles are associated with TrkA receptors, whereas only a subset 
of them associate with P75, and %uo-proNGF particles associate with both TrkA and P75 receptors. !us, the 
two neurotrophin forms would compete for TrkA binding. !e nature of proNGF - TrkA interaction is still elu-
sive and likely occurs with less a$nity than NGF-TrkA interaction37; in any case, free TrkA could be necessary 
for proNGF internalization, and sequestration of free TrkA by NGF could a"ect proNGF transport so that the 
only possibility is that it enters via p75; the latter has well recognized slower internalization rate compared to 
TrkA in peripheral neurons12, and this could #nally result in a reduction of %uo-proNGF transport compared 
to that of %uo-NGF in our observation-time window. However, NGF/proNGF reciprocal signalling per se may 
alter endocytosis and transport. !us another possibility is that NGF, rather than being a simple competitor 
of proNGF for TrkA receptor binding, activates some signalling pathway that prevents proNGF to internalize. 
It is useful to recall here that di"erent proNGF/NGF mixtures exert a signalling pro#le that is di"erent from 
that raised separately by the two neurotrophins and that depends on the ratio between the two proteins7. In 
any case, whatever the competition mechanism, the most important #nding emerging from these data is that 
proNGF retrograde signalling, which is likely to be pro-apoptotic, can emerge more when an NGF trophic 
signalling is absent. One could therefore expect that NGF pro-survival signalling is dominant with respect to 
proNGF one. Alterations in the NGF to proNGF ratios might have direct consequences in the transport %uxes 
and hence in the availability of the two NTs in a competitive way, adding a new functional consequence to the 
emerging importance of the homeostatic regulation of proNGF to NGF metabolism9,38.
From a general perspective, then, the labeling platform proposed here could also be exploited to achieve the 
puri#cation of vesicles carrying NTs and/or the respective proNTs, leading to a proteomic characterization of 
NT signalling endosomes. !is would lately allow to discover whether the molecular composition and identity 
of tra$c and signalling endosomes are dependent on the transported cargo39,40. Furthermore, we envisage the 
possibility of using our approach for the setup of chemical or functional genomic screening assays for compounds 
or genes that regulate the velocity of NTs transport.
Materials  and  Methods
???????????? ??????????? ????????????? ?? ?????????? ??? ???????? Human proNGF cDNA cloned 
in pET11 vector22 was used as template. !e cDNA coding sequences of each tag was inserted into proNGF, by 
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using an insertional mutagenesis procedure adapted from the site-directed mutagenesis method24. wt and tagged 
proNGF proteins were expressed in E. coli and puri#ed using a modi#ed protocol22 from the previously published 
method28.
Labelling  of  tagged  proNGF  and  NGF.   10 µ g of proNGF-YBBR or NGF-YBBR were incubated for 
30 minutes at 37 °C in a thermomixer at 300 rpm with a reaction mix (10 mM MgCl2, 10 µ M CoA-alexa488/
CoA-alexa 647 or CoA-biotin and 2 µ M Sfp Synthase (SfpS) (New England Biolabs), in phosphate bu"er up to 
250 µ l #nal volume. !e synthesis of CoA-biotin and CoA-%uorophore conjugates has been performed as previ-
ously described37.
?????? ??????? ????????????? PC12 (ATCC, CRL-1721) cells were maintained in a humidi#ed atmosphere 
at 37 °C, 5% CO2 in RPMI1640 medium supplemented with 10% horse serum, 5% fetal bovine serum and 1% 
penicillin/streptomycin (Gibco). TF1 cells were cultured in RPMI 1640 medium, 10% fetal bovine serum and 
1% penicillin/streptomycin (Gibco), supplemented with 2 ng/ml recombinant human GM-CSF (R&D Systems 
Inc.). !e TF1 proliferation assay was performed in 96 wells microtiter plates by incubating 15,000 cells per well 
in the presence of increasing doses of either wild type hNGF and NGF-YBBR or NGF-A4, ranging between 5 and 
50,000 pg/ml.
Rat Dorsal Root Ganglion Neurons (R-EDRG-515 AMP, Lonza) were maintained in a humidi#ed atmosphere 
at 37 °C, 5% CO2 in Primary Neuron Basal medium (PNBM, Lonza) supplemented with L-glutamine, NSF-1 (2% 
#nal concentration ) and antibiotics, following the manufacturer’s instructions. For DRG neurons survival the 
media was supplemented by 100 ng/ml of NGF and was replaced every 4–5 days with a pre-warmed fresh one, 
being careful to always leave the main channels #lled. When neurons were plated in micro%uidic devices, a NGF 
gradient (obtained leaving the SC with 50 ng/ml of NGF, and the AC in the presence of 100 ng/ml) was used to 
induce axons to grow in the CC and to reach the AC. DIV8-15 cultures of DRG neurons were used in all exper-
iments: within this range, we did not detect signi#cant changes in the NT vesicles transport. In all the transport 
experiments, the %uorescent NT has been administered in fresh media (not supplemented with NGF) by remov-
ing from the administration compartment all the pre-existing media.
???????? ????? In order to quantify proNGF and NGF biotinylation reaction yields, 2 µ l of all NGF/proNGF 
biotinylation reactions were treated under denaturing conditions (100 °C, 8 minutes in 2X Laemmli Sample 
Bu"er), loaded on two gels (1 µ l for each gel) and electrotransferred to two PVDF membranes respectively. !ese 
were blocked in TBST + 5% w/v BSA, then one of them was blotted with anti-NGF antibody (sc-549, Santa 
Cruz Biotechnology) (1:2000), while the other one was incubated with HRP-conjugated streptavidin (Zymed® ) 
1:10000 diluted in blocking solution.
To study the signal transduction e"ectors, PC12 cells were cultured in P100 Petri dish to reach con%uence, 
starved o.n. in a serum-free medium and then incubated with native NGF, tagged NGF, biot-NGF and %uo-NGF 
(150 ng/ml) at 37 °C. A'er 15 min cells were washed in ice-cold PBS and lysed in RIPA bu"er supplemented with 
proteases and phosphatases inhibitors. 50 µ g of each clari#ed lysate were loaded on a gel and electrotransferred 
to PVDF membranes. !ese were #rst blotted using the antibody anti-Phospho-PLCγ 1, anti-Phospho-p44/42 
MAPK and anti-Phospho-Akt. !e primary antibody was detected by using an anti-mouse or rabbit secondary 
antibody HRP-conjugated.
Microscopy.   All microscopy measurements have been conducted in a wide #eld microscope (Leica DM6000, 
equipped with a 4-laser TIRF-AM module) at 37 °C, 5% CO2. Transmitted light imaging has been performed in 
di"erential interference contrast (DIC) con#guration. For epi-%uorescence microscopy 488 and 633 solid state 
lasers have been used to excite Alexa488 and Alexa647 respectively.
Single  Particle  Tracking  and  Number  analysis.   Single Particle Tracking analysis was performed by cus-
tom made Matlab scripts following the approach previously described41. Colocalizing trajectories were estimated 
by visual inspections of extracted trajectories in the green and red %uorescence channels, a'er an initial automatic 
selection based on the average time and positions of each trajectory in each micro%uidic channel.
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